-transparent.png){kind=logo}
An open trial of a new psychotropic drug, lenperone, was carried out in 10 patients with acute schizophrenia. The duration of treatment was 28 days and the maximum dose administered was 60 mg per day. A pronounced antipsychotic effect was seen in half of the patients, although all 10 patients showed a pharmacological response to the drug. The incidence of side-effects was low. Haematological, biochemical and electrocardiographic tests failed to demonstrate any abnormality due to treatment.
Related Publications
B R Nakra, and
C J Jones, and
A K Majumdar, and
R Gaind
January 1975,
Journal of clinical pharmacology,
B R Nakra, and
C J Jones, and
A K Majumdar, and
R Gaind
January 1971,
Psychiatria polska,
B R Nakra, and
C J Jones, and
A K Majumdar, and
R Gaind
January 1970,
Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology,
B R Nakra, and
C J Jones, and
A K Majumdar, and
R Gaind
December 1971,
Revista espanola de las enfermedades del aparato digestivo,
B R Nakra, and
C J Jones, and
A K Majumdar, and
R Gaind
January 1964,
Psychosomatics,
B R Nakra, and
C J Jones, and
A K Majumdar, and
R Gaind
January 1982,
Arzneimittel-Forschung,
B R Nakra, and
C J Jones, and
A K Majumdar, and
R Gaind
January 1952,
Medical bulletin. St. Louis University,
B R Nakra, and
C J Jones, and
A K Majumdar, and
R Gaind
November 1975,
Current therapeutic research, clinical and experimental,
B R Nakra, and
C J Jones, and
A K Majumdar, and
R Gaind
January 1979,
Annales medico-psychologiques,
B R Nakra, and
C J Jones, and
A K Majumdar, and
R Gaind
January 1973,
L'Encephale,
